Photo from UroToday/X
Aug 27, 2024, 23:00
The shift from ADT monotherapy to triple therapy in mHSPC – UroToday
UroToday shared on X:
“Best practices for successfully implementing triplet therapy in mHSPC. Chris Pieczonka and Zach Klaassen discuss managing mHSPC emphasizing the shift from ADT monotherapy to triple therapy. Watch now.”
Source: UroToday/X
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Feb 21, 2025, 10:07
Feb 21, 2025, 09:58
Feb 21, 2025, 09:54
Feb 21, 2025, 09:45
Feb 21, 2025, 09:35
Feb 21, 2025, 09:18
Feb 21, 2025, 09:07
Feb 21, 2025, 09:00